(Q36218336)

12 August 2017

0 references

Impact of hepatitis C virus on immune restoration in HIV-infected patients who start highly active antiretroviral therapy: a meta-analysis (English)

1 reference

12 August 2017

main subject

anti-retroviral agent

0 references

1 reference

1 reference

1 reference

Melissa Farmer Miller

1

1 reference

12 August 2017

Clinton Haley

2

1 reference

12 August 2017

Margaret James Koziel

3

1 reference

12 August 2017

Christopher F Rowley

4

1 reference

12 August 2017

language of work or name

English

0 references

publication date

22 July 2005

1 reference

Clinical Infectious Diseases

12 August 2017

published in

1 reference

12 August 2017

volume

41

1 reference

12 August 2017

issue

5

1 reference

12 August 2017

page(s)

713-720

1 reference

Hepatitis C Virus prevalence among patients infected with Human Immunodeficiency Virus: a cross-sectional analysis of the US adult AIDS Clinical Trials Group

12 August 2017

cites work

1 reference

Peer review. A view from another pier

21 January 2018

1 reference

Hepatitis C virus infection-related morbidity and mortality among patients with human immunodeficiency virus infection

21 January 2018

1 reference

Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: the Swiss HIV Cohort Study

21 January 2018

1 reference

Coinfection with hepatitis viruses and outcome of initial antiretroviral regimens in previously naive HIV-infected subjects

21 January 2018

1 reference

Impaired recovery of CD4+ cell counts following highly active antiretroviral therapy in drug-naïve patients coinfected with human immunodeficiency virus and hepatitis C virus

21 January 2018

1 reference

Is hepatitis C virus co-infection associated with survival in HIV-infected patients treated by combination antiretroviral therapy?

21 January 2018

1 reference

Immune recovery is associated with persistent rise in hepatitis C virus RNA, infrequent liver test flares, and is not impaired by hepatitis C virus in co-infected subjects

21 January 2018

1 reference

The impact of hepatitis C virus coinfection on HIV progression before and after highly active antiretroviral therapy.

21 January 2018

1 reference

Hepatitis C and progression of HIV disease

21 January 2018

1 reference

Impact of chronic hepatitis B virus (HBV) infection on outcomes of patients infected with HIV in an area where HBV infection is hyperendemic

21 January 2018

1 reference

Operating characteristics of a rank correlation test for publication bias

21 January 2018

1 reference

Bias in meta-analysis detected by a simple, graphical test

21 January 2018

1 reference

Influence of coinfection with hepatitis C virus on morbidity and mortality due to human immunodeficiency virus infection in the era of highly active antiretroviral therapy

21 January 2018

1 reference

Peginterferon Alfa-2a plus ribavirin for chronic hepatitis C virus infection in HIV-infected patients

21 January 2018

1 reference

Peginterferon Alfa-2a plus ribavirin versus interferon alfa-2a plus ribavirin for chronic hepatitis C in HIV-coinfected persons

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1086/432618

1 reference

12 August 2017

1 reference